Nupal Remedies Profile
Key Indicators
- Authorised Capital ₹ 8.00 M
as on 24-10-2024
- Paid Up Capital ₹ 8.00 M
as on 24-10-2024
- Company Age 30 Year, 7 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 6.02 Cr
as on 24-10-2024
- Satisfied Charges ₹ 1.95 M
as on 24-10-2024
- Revenue 28.33%
(FY 2023)
- Profit 2790.81%
(FY 2023)
- Ebitda 50.30%
(FY 2023)
- Net Worth 83.99%
(FY 2023)
- Total Assets 8.95%
(FY 2023)
About Nupal Remedies
The Company is engaged in the E-Commerce Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 8.00 M and a paid-up capital of Rs 8.00 M.
The company currently has active open charges totaling ₹6.02 Cr. The company has closed loans amounting to ₹1.95 M, as per Ministry of Corporate Affairs (MCA) records.
Krishna Padmanabhan, Udayakumar Padmanabhan, and Thuruthippallil Roy serve as directors at the Company.
- CIN/LLPIN
U24231KL1994PTC007989
- Company No.
007989
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
17 Jun 1994
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ernakulam
Industry
Company Details
- Location
Ernakulam, Kerala, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Nupal Remedies Private Limited offer?
Nupal Remedies Private Limited offers a wide range of products and services, including Common Disease Medicines, Hair Growth Medicine, Ayurvedic,Herbal Products & Medicine, Ayurvedic Medicine, Cosmetics, Hair & Beauty Products, Body Cream, Digestive System Drugs & Medicines, Gastrointestinal Drugs, Herbal Piles Medicine, Ayurvedic & Herbal Health Supplement.
Who are the key members and board of directors at Nupal Remedies?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Krishna Padmanabhan  | Managing Director | 17-Jun-1994 | Current |
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Udayakumar Padmanabhan | Whole-Time Director | 30-Jun-2000 | Current |
| Thuruthippallil Roy | Whole-Time Director | 17-Jun-1994 | Current |
Financial Performance of Nupal Remedies.
Nupal Remedies Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 28.33% increase. The company also saw a substantial improvement in profitability, with a 2790.81% increase in profit. The company's net worth Soared by an impressive increase of 83.99%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Nupal Remedies?
In 2021, Nupal Remedies had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Canara Bank Creation Date: 30 Mar 2022 | ₹2.80 M | Open |
Canara Bank Creation Date: 01 Dec 2021 | ₹1.09 Cr | Open |
Canara Bank Creation Date: 30 Oct 2021 | ₹2.17 M | Open |
How Many Employees Work at Nupal Remedies?
Nupal Remedies has a workforce of 21 employees as of Mar 30, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Nupal Remedies, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Nupal Remedies's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
